Remove 2011 Remove Cultivation Remove Data Remove DEA
article thumbnail

DEA: Marijuana Plant Seizures Spike, Arrests Fall in 2019

NORML

Federal law enforcement agents and their partners made fewer marijuana-related arrests in 2019, but seized a far greater number of plants than they did the year before, according to annual data compiled by US Drug Enforcement Administration. It was the second-lowest number of arrests reported by the DEA in the past decade.

DEA 276
article thumbnail

DEA Report Shows Marijuana Arrests And Seizures Up In 2020

SpeedWeed

Data recently released by the U.S. The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. DEA Report Shows Federal Prohibition Efforts Continue Despite State-Level Reforms.

DEA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NORML: DEA Reports Significant Uptick in Marijuana-Related Seizures, Arrests

Cannabis Law Report

million cultivated marijuana plants and made more than 6,600 marijuana-related arrests in 2021, according to annual data compiled by the US Drug Enforcement Administration. . million cultivated cannabis plants last year – a 20 percent increase over 2020’s totals. million plants via its domestic eradication program.

DEA 52
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D., million in the form of a bequest.

article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

In 2011, Reps. The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. Similar bills have been introduced perennially since then, most recently by Rep. 2 1 U.S.C. §

Banking 45